Meta-Analysis Comparing Outcomes of Self-Expanding Versus Balloon-Expandable Valves for Transcatheter Aortic Valve Implantation

Transcatheter aortic valve implantation (TAVI) has revolutionized the management of patients with symptomatic severe aortic stenosis. Recently, the role of TAVI has expanded from the high surgical risk to low surgical risk patients.1-4 There are two commercially available transcatheter heart valve systems: self-expanding and balloon-expanding valves. In the pivotal trials comparing TAVI with surgical aortic valve replacement (SAVR), only one system was utilized in the individual trials.1,2,5-8 Studies providing a direct comparison between both devices are scarce.

Source: The American Journal of Cardiology - May 15, 2020 Category: Cardiology Authors: Islam Y. Elgendy, Mohamed M. Gad, Ahmed N. Mahmoud, Danny Dvir, Samir R. Kapadia, Fernando Alfonso, Davide Capodanno Source Type: research